Ropes & Gray represented CAMP4 Therapeutics in the transaction, and Paul Hastings represented the underwriters. CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biotechnology company, announced...
CAMP4 Therapeutics’ $75 Million IPO
Advent and Warburg Pincus’ Acquisition of BioPharma Solutions from Baxter
Cleary Gottlieb Steen & Hamilton and Ropes & Gray are serving as legal advisor to Advent and Warburg Pincus, while Sullivan & Cromwell is serving as...
GHO Capital and The Vistria Group’s Acquisition of Alcami
Ropes & Gray represented GHO Capital and The Vistria Group, while Kirkland & Ellis represented Alcami in the transaction. GHO Capital and The Vistria Group announced...
Taro Pharmaceutical Industries’ Acquisition of Alchemee
Cravath and Lenz & Staehelin represented Taro in connection with the transaction. Ropes & Gray advised Galderma. Taro Pharmaceutical Industries Ltd. (“Taro”), a multinational, science-based pharmaceutical...
Amplity Health’s Merger with The Lynx Group
Ropes & Gray advised Amplity Health, while Greenberg Traurig advised The Lynx Group on the deal. Altamont Capital Partners portfolio company Amplity Health announced its merger...
Galderma’s Acquisition of Alastin Skincare
Ropes & Gray advised Galderma on the deal, while Latham & Watkins advised ALASTIN. Galderma, one of the world’s largest independent dermatology companies, executed its acquisition...